Found: 33
Select item for more details and to access through your institution.
Primary resistance to first-generation EGFR-TKIs induced by MDM2 amplification in NSCLC.
- Published in:
- Molecular Medicine, 2020, v. 26, n. 1, p. 1, doi. 10.1186/s10020-020-00193-z
- By:
- Publication type:
- Article
Chronic arsenite exposure induced skeletal muscle atrophy by disrupting angiotensin II‐melatonin axis in rats.
- Published in:
- Environmental Toxicology, 2024, v. 39, n. 3, p. 1350, doi. 10.1002/tox.24027
- By:
- Publication type:
- Article
Pivotal Role of Fatty Acid Synthase in c-MYC Driven Hepatocarcinogenesis.
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 22, p. 8467, doi. 10.3390/ijms21228467
- By:
- Publication type:
- Article
Subchronic Arsenite Exposure Induced Atrophy and Erythropoietin Sensitivity Reduction in Skeletal Muscle Were Relevant to Declined Serum Melatonin Levels in Middle-Aged Rats.
- Published in:
- Toxics, 2023, v. 11, n. 8, p. 689, doi. 10.3390/toxics11080689
- By:
- Publication type:
- Article
Subchronic Low-Dose Methylmercury Exposure Accelerated Cerebral Telomere Shortening in Relevant with Declined Urinary aMT6s Level in Rats.
- Published in:
- Toxics, 2023, v. 11, n. 2, p. 191, doi. 10.3390/toxics11020191
- By:
- Publication type:
- Article
The role of CD28 in the prognosis of young lung adenocarcinoma patients.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Family History of Hypertension and Cobalt Exposure Synergistically Promote the Prevalence of Hypertension.
- Published in:
- Biological Trace Element Research, 2022, v. 200, n. 3, p. 943, doi. 10.1007/s12011-021-02707-0
- By:
- Publication type:
- Article
Bmi1 Is Required for Hepatic Progenitor Cell Expansion and Liver Tumor Development.
- Published in:
- PLoS ONE, 2012, v. 7, n. 9, p. 1, doi. 10.1371/journal.pone.0046472
- By:
- Publication type:
- Article
Optimal Treatments for NSCLC Patients Harboring Primary or Acquired MET Amplification.
- Published in:
- Technology in Cancer Research & Treatment, 2022, v. 21, p. 1, doi. 10.1177/15330338221128414
- By:
- Publication type:
- Article
The Effect of Selective c-MET Inhibitor on Hepatocellular Carcinoma in the MET-Active, β-Catenin-Mutated Mouse Model.
- Published in:
- Gene Expression (1052-2166), 2018, v. 18, n. 2, p. 135, doi. 10.3727/105221618X15174108894682
- By:
- Publication type:
- Article
Novel Advances in Understanding of Molecular Pathogenesis of Hepatoblastoma: A Wnt/β-Catenin Perspective.
- Published in:
- Gene Expression (1052-2166), 2017, v. 17, n. 2, p. 141, doi. 10.3727/105221616X693639
- By:
- Publication type:
- Article
β-Catenin-NF-κB-CFTR interactions in cholangiocytes regulate inflammation and fibrosis during ductular reaction.
- Published in:
- eLife, 2021, p. 1, doi. 10.7554/eLife.71310
- By:
- Publication type:
- Article
Corrigendum: Eupafolin Suppresses Esophagus Cancer Growth by Targeting T-LAK Cell-Originated Protein Kinase Protein Kinase.
- Published in:
- 2020
- By:
- Publication type:
- Correction Notice
Eupafolin Suppresses Esophagus Cancer Growth by Targeting T-LAK Cell-Originated Protein Kinase.
- Published in:
- Frontiers in Pharmacology, 2019, v. 10, p. 1, doi. 10.3389/fphar.2019.01248
- By:
- Publication type:
- Article
Advancement in research and therapy of NF1 mutant malignant tumors.
- Published in:
- Cancer Cell International, 2020, v. 20, n. 1, p. 1, doi. 10.1186/s12935-020-01570-8
- By:
- Publication type:
- Article
Activated mutant forms of PIK3 CA cooperate with RasV12 or c-Met to induce liver tumour formation in mice via AKT2/ mTORC1 cascade.
- Published in:
- Liver International, 2016, v. 36, n. 8, p. 1176, doi. 10.1111/liv.13055
- By:
- Publication type:
- Article
Role of ncRNAs in Hepatocellular Carcinoma.
- Published in:
- BioMed Research International, 2018, v. 2018, p. 1, doi. 10.1155/2018/3014543
- By:
- Publication type:
- Article
HSF1 Signaling Inhibits Apoptosis in Hepatoblastoma.
- Published in:
- FASEB Journal, 2022, v. 36, p. N.PAG, doi. 10.1096/fasebj.2022.36.S1.R4190
- By:
- Publication type:
- Article
Investigating the therapeutic efficacy of a novel mTORC1 inhibitor, RMC‐6272, on liver tumors with b‐catenin activation.
- Published in:
- FASEB Journal, 2022, v. 36, p. N.PAG, doi. 10.1096/fasebj.2022.36.S1.R4865
- By:
- Publication type:
- Article
Understanding Molecular Heterogeneity in Hepatocellular Carcinoma.
- Published in:
- FASEB Journal, 2022, v. 36, p. N.PAG, doi. 10.1096/fasebj.2022.36.S1.R5218
- By:
- Publication type:
- Article
Therapeutic implication of SOX9 and YAP1 co‐repression in advanced intrahepatic cholangiocarcinoma.
- Published in:
- FASEB Journal, 2022, v. 36, p. N.PAG, doi. 10.1096/fasebj.2022.36.S1.R3050
- By:
- Publication type:
- Article
Investigating Susceptibility of ꞵ‐catenin‐mutated Hepatocellular Carcinoma to Checkpoint Inhibitors.
- Published in:
- FASEB Journal, 2022, v. 36, p. N.PAG, doi. 10.1096/fasebj.2022.36.S1.R2950
- By:
- Publication type:
- Article
p‐Ezrin (Thr567) synergizes with Akt signaling to accelerate Yap mediated cholangiocarcinogenesis, but correlates with favorable prognosis in human intrahepatic cholangiocarcinoma(ICC) patients.
- Published in:
- FASEB Journal, 2021, v. 35, p. N.PAG, doi. 10.1096/fasebj.2021.35.S1.04062
- By:
- Publication type:
- Article
Role of YES1 amplification in EGFR mutation‐positive non‐small cell lung cancer: Primary resistance to afatinib in a patient.
- Published in:
- Thoracic Cancer, 2020, v. 11, n. 9, p. 2736, doi. 10.1111/1759-7714.13583
- By:
- Publication type:
- Article
Oncogenic potential of N-terminal deletion and S45Y mutant β-catenin in promoting hepatocellular carcinoma development in mice.
- Published in:
- 2018
- By:
- Publication type:
- journal article
ORN: Inferring patient-specific dysregulation status of pathway modules in cancer with OR-gate Network.
- Published in:
- PLoS Computational Biology, 2021, v. 17, n. 4, p. 1, doi. 10.1371/journal.pcbi.1008792
- By:
- Publication type:
- Article
Correction: The Hippo pathway efector TAZ induces intrahepatic cholangiocarcinoma in mice and is ubiquitously activated in the human disease.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Correction: The Hippo pathway efector TAZ induces intrahepatic cholangiocarcinoma in mice and is ubiquitously activated in the human disease.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Correction: The Hippo pathway efector TAZ induces intrahepatic cholangiocarcinoma in mice and is ubiquitously activated in the human disease.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Correction: The Hippo pathway efector TAZ induces intrahepatic cholangiocarcinoma in mice and is ubiquitously activated in the human disease.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Role of YES1 signaling in tumor therapy resistance.
- Published in:
- Cancer Innovation, 2023, v. 2, n. 3, p. 210, doi. 10.1002/cai2.51
- By:
- Publication type:
- Article
The Hippo pathway effector TAZ induces intrahepatic cholangiocarcinoma in mice and is ubiquitously activated in the human disease.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2022, v. 41, n. 1, p. 1, doi. 10.1186/s13046-022-02394-2
- By:
- Publication type:
- Article
Embryonic benzophenone-3 exposure inhibited fertility in later-life female zebrafish and altered developmental morphology in offspring embryos.
- Published in:
- Environmental Science & Pollution Research, 2023, v. 30, n. 17, p. 49226, doi. 10.1007/s11356-023-25843-7
- By:
- Publication type:
- Article